CHF 25 million Swiss francs for FLASH radiotherapy

The ISREC Foundation and Lausanne University Hospital (CHUV) have announced that funding is now secured for the translation to the clinic of a leading-edge radiotherapy technology to treat the most resistant types of cancers. This innovative development in radiotherapy selectively kills tumour cells while sparing healthy tissues. Its successful entry into the clinic would be a first world-wide and could be used to treat a broad range of cancer patients with FLASH therapy. The 25 million Swiss Francs donation extends initial efforts pioneered by radiation oncology at CHUV and will enable its specialists to collaborate with CERN’s experts in accelerator technologies, to design and construct a dedicated FLASH radiotherapy platform.

This project is funded thanks to a private donation from the BILTEMA Foundation to the ISREC Foundation.